0125 GMT - Sigma Healthcare gets a new bear at Jefferies as its merger with privately owned Chemist Warehouse moves slowly toward the finish line. Analyst David Stanton tells clients in a note that, following the latest update from Australia's competition regulator, he now expects the merger to complete by the end of February. He had previously been eyeing the end of this month. Jefferies raises its fiscal 2025 forecasts for Chemist Warehouse sales and margins, supporting a 16% rise in its target price for Sigma shares to A$1.85. However, the stock's recent advance leads the investment bank to cut its recommendation to underperform from hold. Shares are down 1.95% at A$2.765. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
December 11, 2024 20:25 ET (01:25 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.